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Abstract
The mortality rate of aneurysmal subarachnoid hemorrhage (aSAH) can be 
as high as 70 percent. Of patients whom survive, 25-30 percent develop 
some degree of vasospasm up to 21 days after initial onslaught. Vasospasm 
is the second leading cause of death and disability in patients with 
subarachnoid hemorrhage (SAH). The American Stroke Association (ASA) 
guidelines for management of SAH recommend oral Nimodipine and 
endovascular treatments to limit detrimental effects of vasospasm. In 
patients with severe, unrelenting vasospasm, outcomes within an academic, 
community Magnet® hospital have shown promising results when 
implementing alternative therapies after radiographic evidence that 
vasospasm is not resolving by endovascular intervention. This presentation 
details the pathophysiology of vasospasm, outlines ASA guidelines for 
treatment of aSAH, and uses two case studies to present alternative 
treatment options including targeted temperature management, intravenous 
Milrinone, low dose Nicardipine infusions, and intra-thecal medication 
administration. 
Objectives
1.  Outline the published American Stroke Association guidelines for the 
management of aSAH.
2.  Discuss the pathophysiology of vasospasm in the aSAH patient.
3.  Detail two case studies that demonstrate that the addition of targeted 
temperature management cooling, intravenous Milrinone, intravenous 
low-dose Nicardipine and intra-thecal medication administration may be 
adjunct therapies in angiographic vasospasm limiting the severity of the 
spasm and improving patient outcomes. 
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Case Studies
1Hunt and Hess grade 4, modi-fied Fisher 4 subarachnoid 
hemorrhage secondary to a 
 ruptured left anterior commu­
nicating artery aneurysm in a 
29­year­old female
 a.  Coil assisted embolization  
with secured aneurysm 
 b.  Hemi-craniotomy with external 
ventricular device (EVD) 
 c.  Symptomatic vasospasm  
on day #4 
  •  Intra-arterial Verapamil 
administration
 d.  Symptomatic vasospasm of 
internal carotid arteries and 
middle cerebral arteries 
  •  Daily to Interventional Radiology
 e.  Vasospasm/cerebral edema 
unrelenting leading to adjunct 
treatment options
  •  Intrathecal nicardipine 
  •  Serum NA goal 155-160 
  •  Intravascular cooling 
  •  Low dose Nicardipine infusion
  •  Intravenous Milrinone infusion
  •  Medically induced (pentobarbital) 
coma on day #16
 f.  Discharged to rehabilitation 
hospital after 38 days 
2 Hunt and Hess grade 3, modi-fied fisher 4 subarachnoid 
hemorrhage secondary to 
 ruptured posterior commu ­
nicating aneurysm rupture in a 
57­year­old female
a.  Aneurysm clipped on day #1
b.  Vasospasm on hospital day #4 
  •  Middle cerebral artery and 
bilateral internal carotid artery
c.  Interventional Radiology for IV 
Verapamil X 10 consecutive days 
d.  Received continuous low dose 
Nicardipine as an adjunct therapy 
e.  Received intravascular targeted 
temperature management 
f.  Chemically paralyzed to optimize 
ventilation and impact shiver 
threshold
g.  Tracheostomy and percutaneous 
endoscopic gastrostomy (PEG)  
on day #28 
h.  Transfer to medical-surgical unit 
on hospital day #33
i.  Transfer to inpatient rehabilitation 
unit on day #45
j.  Discharge home with husband on 
day #66 
Management of aSAH
1.  aSAH affects 30,000 people annually in the 
United States
 a.  Location of aneurysm is a prognostication  
of survival and potential neurological deficits
2.  Clinical manifestations and diagnosis of aSAH
 a.  Complaint of “worst headache of my life”
 b.  Sentinel bleed or warning leak
3.  Surgical and endovascular methods for 
treatment of ruptured aneurysms
 a.  Surgical clipping in patients with large  
(>50 mL) 
 b.  Surgical clipping recommended for wide  
base aneurysm
 c.  Endovascular coiling patients > 70 years  
of age
 d.  Endovascular coiling consideration in 
aneurysms if in the basilar apex
4.  Management of cerebral vasospasm and 
delayed cerebral ischemia
 a.  Oral Nimodipine should be administered to  
all patients with aSAH
 b.  Maintenance of euvolemia and circulating 
blood volume
 c.  Induction of hemodynamic augmentation to 
improve cerebral perfusion
 d.  Cerebral angioplasty and/or intra-arterial 
vasodilation 
Management of Cerebral Vasospasm 
and Delayed Cerebral Ischemia
1.  Any neurological deterioration presumed to be 
related to ischemia that lasts for more than  
one hour
 a.  Angiographic narrowing of arteries 
 b.  Elevated cerebral blood flow velocities 
 c.  Occurs 7 to 10 days after rupture and 
resolves spontaneously after 21 days
 d.  Major cause of death and disability 
2.  Oxyhemoglobiin comes in contact with the 
abluminal side of a vessel
3.  Depletion of nitric oxide causes cerebral 
vasoconstriction
4.  Free radical oxidation of bilirubin stimulates 
vasoconstriction 
5.  Inflammation and leukocyte adherence to the 
vascular endothelium 
6.  Presence of cytokine proteins in the vasculature
